PRESS RELEASE published on 04/28/2026 at 19:00, 1 month 23 days ago THX Pharma publie ses résultats annuels 2025, sa trésorerie au 31 mars 2026 et fait le point sur ses activités THX Pharma publie ses résultats annuels 2025, trésorerie en hausse à 22,3 M€. Accord stratégique avec Biocodex renforce solidité financière. Focus sur développements cliniques et commercialisation Résultats Annuels Trésorerie Accord Stratégique Développements Cliniques THX Pharma
PRESS RELEASE published on 04/28/2026 at 19:00, 1 month 23 days ago THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update THX Pharma announces annual results, cash position, and strategic partnerships, including Biocodex agreement. Financial stability secured. Focus on clinical development and commercialization of TX01 and Batten-1 Strategic Partnership Financial Stability Neurological Diseases THX Pharma Biocodex
BRIEF published on 03/25/2026 at 18:50, 2 months 27 days ago THX Pharma Publishes Letter to Shareholders Innovation Shareholders Licensing Agreements Neurological Diseases THX Pharma
BRIEF published on 03/25/2026 at 18:50, 2 months 27 days ago Theranexus publie sa lettre aux actionnaires Actionnaires Biopharmaceutique Médicaments Theranexus Neurologie
BRIEF published on 03/25/2026 at 18:50, 2 months 27 days ago Theranexus publishes its letter to shareholders Shareholders Biopharmaceutical Neurology Theranexus Drugs
BRIEF published on 03/25/2026 at 18:50, 2 months 27 days ago THX Pharma publie une lettre aux actionnaires Innovation Actionnaires Accords De Licence Maladies Neurologiques THX Pharma
PRESS RELEASE published on 03/25/2026 at 18:45, 2 months 27 days ago THX Pharma annonce la publication de sa lettre aux actionnaires THX Pharma (Theranexus) annonce la publication de sa lettre aux actionnaires sur les traitements neurologiques rares. Découvrez les détails et inscrivez-vous pour recevoir les communications Communications Lettre Aux Actionnaires Theranexus THX Pharma Traitements Neurologiques Rares
PRESS RELEASE published on 03/25/2026 at 18:45, 2 months 27 days ago THX Pharma Announces the Publication of its Letter to Shareholders THX Pharma (Theranexus) announces the publication of a letter to shareholders regarding its innovative treatments for rare neurological diseases. Company details and contact information included Shareholders Biopharmaceutical Theranexus Neurological Diseases THX Pharma
BRIEF published on 02/25/2026 at 18:05, 3 months 24 days ago THX Pharma increases the resources of its liquidity contract Liquidity Contract Euronext Growth Biopharmaceutical Financial Resources THX Pharma
BRIEF published on 02/25/2026 at 18:05, 3 months 24 days ago THX Pharma augmente les moyens de son contrat de liquidité Contrat De Liquidité Euronext Growth Biopharmaceutique Moyens Financiers THX Pharma
Published on 06/20/2026 at 01:00, 2 days 7 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 8 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 3 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 6 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 08:00, 12 minutes ago Coinsilium Group Limited: ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
Published on 06/22/2026 at 07:30, 41 minutes ago NAGRAVISION Launches NAGRA® Venturi, Intelligence-Led Streaming Security for the AI EraTitle
Published on 06/19/2026 at 19:33, 2 days 12 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 12 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 12 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 12 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026